332 related articles for article (PubMed ID: 15841178)
1. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.
Payne AS; Ishii K; Kacir S; Lin C; Li H; Hanakawa Y; Tsunoda K; Amagai M; Stanley JR; Siegel DL
J Clin Invest; 2005 Apr; 115(4):888-99. PubMed ID: 15841178
[TBL] [Abstract][Full Text] [Related]
2. Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies.
Ishii K; Lin C; Siegel DL; Stanley JR
J Invest Dermatol; 2008 Apr; 128(4):939-48. PubMed ID: 18007588
[TBL] [Abstract][Full Text] [Related]
3. Targeting pemphigus autoantibodies through their heavy-chain variable region genes.
Payne AS; Siegel DL; Stanley JR
J Invest Dermatol; 2007 Jul; 127(7):1681-91. PubMed ID: 17392832
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris.
Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA
PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671
[TBL] [Abstract][Full Text] [Related]
5. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
6. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.
Di Zenzo G; Di Lullo G; Corti D; Calabresi V; Sinistro A; Vanzetta F; Didona B; Cianchini G; Hertl M; Eming R; Amagai M; Ohyama B; Hashimoto T; Sloostra J; Sallusto F; Zambruno G; Lanzavecchia A
J Clin Invest; 2012 Oct; 122(10):3781-90. PubMed ID: 22996451
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic anti-desmoglein 3 mAbs cloned from a paraneoplastic pemphigus patient by phage display.
Saleh MA; Ishii K; Yamagami J; Shirakata Y; Hashimoto K; Amagai M
J Invest Dermatol; 2012 Apr; 132(4):1141-8. PubMed ID: 22277944
[TBL] [Abstract][Full Text] [Related]
8. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
10. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
12. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.
Yoshida K; Ishii K; Shimizu A; Yokouchi M; Amagai M; Shiraishi K; Shirakata Y; Stanley JR; Ishiko A
J Dermatol Sci; 2017 Mar; 85(3):197-207. PubMed ID: 28024684
[TBL] [Abstract][Full Text] [Related]
13. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K
J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
[TBL] [Abstract][Full Text] [Related]
14. Role of intramolecular epitope spreading in pemphigus vulgaris.
Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
[TBL] [Abstract][Full Text] [Related]
15. Pemphigus Vulgaris and Foliaceus IgG Autoantibodies Directly Block Heterophilic Transinteraction between Desmoglein and Desmocollin.
Ishii K; Yoshida K; Stanley JR; Yamagami J; Amagai M; Ishiko A
J Invest Dermatol; 2020 Oct; 140(10):1919-1926.e7. PubMed ID: 32142800
[TBL] [Abstract][Full Text] [Related]
16. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris.
Ishii K; Harada R; Matsuo I; Shirakata Y; Hashimoto K; Amagai M
J Invest Dermatol; 2005 May; 124(5):939-46. PubMed ID: 15854034
[TBL] [Abstract][Full Text] [Related]
17. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients.
Qian Y; Diaz LA; Ye J; Clarke SH
J Immunol; 2007 May; 178(9):5982-90. PubMed ID: 17442983
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.
Adams MJ; Reichel MB; King IA; Marsden MD; Greenwood MD; Thirlwell H; Arnemann J; Buxton RS; Ali RR
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):165-74. PubMed ID: 9405290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
